KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Invested Capital (2018 - 2025)

Moderna (MRNA) has disclosed Return on Invested Capital for 8 consecutive years, with 0.35% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital fell 2.0% to 0.35% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.35%, a 2.0% decrease, with the full-year FY2025 number at 0.32%, changed 0.0% from a year prior.
  • Return on Invested Capital was 0.35% for Q4 2025 at Moderna, up from 0.36% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.99% in Q4 2021 to a low of 0.68% in Q2 2025.
  • A 5-year average of 0.08% and a median of 0.08% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: soared 127bps in 2021, then plummeted -89bps in 2023.
  • Moderna's Return on Invested Capital stood at 0.99% in 2021, then plummeted by -58bps to 0.42% in 2022, then plummeted by -189bps to 0.37% in 2023, then grew by 11bps to 0.33% in 2024, then dropped by -5bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Return on Invested Capital are 0.35% (Q4 2025), 0.36% (Q3 2025), and 0.68% (Q2 2025).